Oct. 14 (Fri.) ,2016 12:00-13:00

Annex Hall

Public Institution

JETRO (Japan External Trade Organization)

Business Trends and Opportunities for Japan's Life Science Sector: Deregulation, Expedited Approval, Open Innovation

Japan’s life science sector is open for business and innovation. The government of Japan has implemented a series of regulatory reforms to create more opportunities for business and innovation in Japan. Japan’s changes include deregulation, subsidization, and introduction of an expedited approval process for certain medical products such as regenerative medicine. This seminar will provide a deeper understanding of the new Japanese regulatory environment and case studies of market entry into Japan as well as discuss current trends regarding open innovation.


Taku Sato

Director, Healthcare Industries Division, JETRO (Japan External Trade Organization)

Opportunities for Japan Pharma Market Entry

Rob Claar

President & CEO, Vorpal Technologies

Case study of Japan market entry

Masako Nakamura

President & Representative Director of Japanese subsidiary, Aegerion Pharmaceuticals

Support program for overseas life science companies seeking business expansion in Japan

Masaki Fujihara

Director, Invest Japan Business Support Center, JETRO (Japan External Trade Organization)

Close Window